Back Home

Maximizing Immunoassay Performance

Maximizing Immunoassay Performance

  • HOME
  • ABOUT US
    • Founders
    • Why InfYnity
    • Who we are
    • What we do
  • OFFER
    • Biomaterial Products
    • Biomaterial Design
    • Immunoassay RUO products
    • Immunoassay Development Services
    • Multiplex Services
  • CONTACT US
    • Careers
  • Pipeline
  • Partners
Home » 2019 » October » 09

News

  • Lancet Infectious Disease publication on an innovative multiplex test for forecasting parasitological cure in Chagas patients
  • InfYnity Multiplex ELISA Platform: Reliable & Highly Reproducible
  • MEDICA (November 18-21, 2019)
  • HERVS & Disease (November 5-6, 2019)
  • Chagas Disease Monitoring: Time for analysis of serological patterns
  • NIH Award to develop a Test-of-Cure for Chagas disease
  • Stars of Science – Session 10 (2018)
  • Chagas Platform Meeting (November 14-15, 2018)
  • MEDICA (November 12-15, 2018)
  • Biotuesday (September 4, 2018)

Daily Archives: October 9, 2019


InfYnity Biomarkers is pleased to announce that our manuscript “The unmet medical need for Trypanosoma cruzi-infected patients: Monitoring the Disease Status” has been published in Biochimica et Biophysica Acta, BBA Molecular Basis of Disease special issue focused on Chagas disease. In this Mini Review Maan Zrein (CSO of InfYnity Biomarkers) […]

Chagas Disease Monitoring: Time for analysis of serological patterns

9 Oct, 2019  in Biotechnology by admin


INFYNITY BIOMARKERS

78-80 rue du Bourbonnais
69009 Lyon – France

Tel: +33 4 72 76 20 29
Fax: +33 9 81 38 17 15
Email: info@infynity-biomarkers.com

Map: https://map.what3words.com/portique.retrouvons.sportif

Mentions Légales

 

· © 2022 infYnity-biomarkers ·

Web Design MymensinghPremium WordPress ThemesWeb Development